R&D and Product Development
Our scientists turn product ideas into stable, scalable and regulatory ready formulations, supported by robust analytical data.

R&D and Product Development by Zanax Healthcare
Great products start with sound science. Whether you need a generic equivalent, a differentiated formulation or a new nutraceutical blend, the development phase decides cost, stability and approval success.
Zanax Healthcare partners with well equipped R&D centres to deliver formulation, analytical method development, ICH stability studies and smooth technology transfer to your chosen manufacturing site.
What We Deliver
Formulation Development
Generic, modified release and novel dosage forms developed to target profiles.
Analytical Development
Method development and validation as per ICH Q2 guidelines.
Stability Studies
Long term and accelerated studies across ICH climatic zones.
Technology Transfer
Scale up from lab to pilot to commercial batches with full documentation.
BE Study Coordination
Bioequivalence study planning with accredited CROs.
Nutraceutical Innovation
Science-backed blends, taste masking and novel delivery formats.
Our Process
Product Brief
Define target product profile, market and regulatory pathway.
Pre-formulation
Excipient compatibility, prototype trials and feasibility batches.
Optimisation
Formula optimisation, analytical validation and stability loading.
Tech Transfer
Scale up batches and complete transfer package to the plant.
Why Clients Choose Us
- Experienced formulation and analytical scientists
- Development aligned with CTD dossier requirements
- Confidentiality agreements and IP protection
- Faster time to market with parallel workstreams
- Seamless link to our manufacturing network
Frequently Asked Questions
Who owns the formulation IP?
For fully funded development projects, the formulation and associated data are transferred to the client as agreed in the development contract.
Can you develop nutraceutical products too?
Yes. We develop tablets, capsules, powders, gummies, effervescent formats and liquids for nutraceutical and wellness brands.
Do you support stability studies for export markets?
Yes. We plan stability protocols for the ICH climatic zones relevant to your target markets, including Zone IVb.
How long does formulation development take?
Timelines vary by complexity. A simple generic formulation can take a few months to reach scale up, while modified release or novel formats take longer due to additional optimisation and stability work.
Can you reverse engineer a reference product?
Yes. We characterise the reference product and develop an equivalent formulation, supported by comparative dissolution and analytical data.
Related Services
Global Pharma Trading
Reliable sourcing and export of finished formulations, APIs and nutraceuticals to regulated and emerging markets worldwide.
Explore ServiceTurnkey Pharma Projects
Concept-to-commissioning support for pharmaceutical and nutraceutical plants designed to WHO-GMP, EU-GMP and US FDA standards.
Explore ServiceProduct Manufacturing
Third party and contract manufacturing of pharmaceutical and nutraceutical products across all major dosage forms.
Explore ServiceReady to Discuss Your R&D and Product Development Requirement?
Share your requirement and our specialists will get back within one business day with a clear plan, timeline and quote.